COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 2475: Articles 24741-24750  | Next

Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats
Nesbitt, D. J., Jin, D., Hogan, J. W., Chan, P. A., Simon, M. J., Vargas, M., King, E., Huard, R. C., Bandy, U., Hillyer, C. D., Luchsinger, L. L.
10.1101/2020.07.20.20157743 — Posted: 2020-07-26
Evidence of gender bias in the diagnosis and management of COVID-19 patients: A Big Data analysis of Electronic Health Records
Ancochea, J., Izquierdo, J. L., Savana COVID-19 Research Group, , Soriano, J. B.
10.1101/2020.07.20.20157735 — Posted: 2020-07-26 Discussion: Onsite | Offsite
The neuropeptides VIP and PACAP inhibit SARS-CoV-2 replication in monocytes and lung epithelial cells and decrease the production of proinflammatory cytokines in infected cells.
Temerozo, J. R., Sacramento, C. Q., Fintelman-Rodrigues, N., Pao, C. R. R., de Freitas, C. S., Dias, S. d. S. G., Ferreira, A. C., Mattos, M., Soares, V. C., Teixeira, L., de Azevedo-Quintanilha, I. G., Kurtz, P., Bozza, F. A., Bozza, P. T., Souza, T. M. L., Bou-Habib, D. C.
10.1101/2020.07.25.220806 — Posted: 2020-07-26
North American deer mice are susceptible to SARS-CoV-2
Griffin, B. D., Chan, M., Tailor, N., Mendoza, E. J., Leung, A., Warner, B. M., Duggan, A. T., Moffat, E., He, S., Garnett, L., Tran, K. N., Banadyga, L., Albietz, A., Tierney, K., Audet, J., Bello, A., Vendramelli, R., Boese, A. S., Fernando, L., Lindsay, L. R., Jardine, C. M., Wood, H., Poliquin, G., Strong, J. E., Drebot, M., Safronetz, D., Embury-Hyatt, C., Kobasa, D.
10.1101/2020.07.25.221291 — Posted: 2020-07-26
CoVaccine HT™ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisation
Haun, B. K., Lai, C.-Y., Williams, C. A., Wong, T. A. S., Lieberman, M. M., Pessaint, L., Elyard, H. A., Lehrer, A. T.
10.1101/2020.07.24.220715 — Posted: 2020-07-26 Discussion: Onsite
Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
Kim, J., Mukherjee, A., Nelson, D., Jozic, A., Sahay, G.
10.1101/2020.07.24.205583 — Posted: 2020-07-25
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2
Vanhove, B., Duvaux, O., Rousse, J., Royer, P.-J., Evanno, G., Ciron, C., Lheriteau, E., Vacher, L., Gervois, N., Oger, R., Jacques, Y., Salama, A., Duchi, R., Perota, A., Delahaut, P., Ledure, M., Paulus, M., So, R., Mok, C. K. P., Bruzzone, R., Bouillet, M., Brouard, S., Cozzi, E., Galli, C., Blanchard, D., Bach, J.-M., Soulillou, J.-P.
10.1101/2020.07.25.217158 — Posted: 2020-07-25
Clustering, diffusion and evolution of COVID19 infections during lock-down
Bos, W., Bertoglio, J.-P., Gostiaux, L.
10.1101/2020.07.22.20159830 — Posted: 2020-07-25
SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine
Hörnich, B. F., Grosskopf, A. K., Schlagowski, S., Tenbusch, M., Neipel, F., Hahn, A. S.
10.1101/2020.07.25.221135 — Posted: 2020-07-25
β-Coronaviruses use lysosomal organelles for cellular egress.
Altan-Bonnet, N., Altan-Bonnet, G. Y., Ghosh, S., Dellibovi-Ragheb, T., Pak, E., Qiu, Q., Fisher, M., Takvorian, P., Bleck, C., Hsu, V., Fehr, A., Perlman, S., Straus, M., Whittaker, G., de Haan, C. A.
10.1101/2020.07.25.192310 — Posted: 2020-07-25 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).